Angel Vila-Rovira
Overview
Explore the profile of Angel Vila-Rovira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vila-Corcoles A, Ochoa-Gondar O, Torrente-Fraga C, Vila-Rovira A, Satue-Gracia E, Hospital-Guardiola I, et al.
Rev Esp Salud Publica
. 2020 Jun;
94.
PMID: 32588837
Objective: Population-based data on the current Covid-19 pandemic is scarce. This study investigated incidence and risk to suffer Covid-19 by baseline underlying conditions in people ≥50 years in Tarragona region...
12.
Vila-Corcoles A, Hospital I, Ochoa-Gondar O, Satue E, de Diego C, Vila-Rovira A, et al.
Vaccine
. 2019 Nov;
38(5):1170-1180.
PMID: 31759735
Background: Clinical benefits using the 23-valent pneumococcal polysaccharide vaccine (PPsV23) or the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness for both PPsV23 and...
13.
Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Vila-Rovira A, Aragon M
Euro Surveill
. 2019 Jul;
24(29).
PMID: 31339099
BackgroundRecent published data on pneumococcal vaccination coverages among adults are scarce.AimTo update on pneumococcal vaccination uptakes among middle-aged and older adults in Catalonia.MethodsWe conducted a population-based retrospective observational study including...
14.
Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Aragon M, Vila-Rovira A, et al.
BMC Infect Dis
. 2018 Apr;
18(1):196.
PMID: 29699550
Background: Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness of PCV13 vaccination in preventing hospitalisation from pneumonia among middle-aged and older...
15.
Ochoa-Gondar O, Vila-Corcoles A, de Diego C, Satue E, Vila-Rovira A, Aragon M
Aten Primaria
. 2018 Jan;
50(9):553-559.
PMID: 29373143
Objectives: To know antipneumococcal vaccination coverages among Catalonian adults and evaluate the adequacy of vaccine use according to 3 distinct current vaccination guidelines. Design: Population-based cross-sectional study. Setting: Primary Health...
16.
Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, de Diego-Cabanes C, Vila-Rovira A, Blade J, et al.
Rev Neurol
. 2014 Nov;
59(11):490-6.
PMID: 25418143
Introduction: Data available about the epidemiology of stroke is limited. This study investigated incidence and lethality of ischaemic stroke among the general population over 60 years in the region of...
17.
Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, de Diego-Cabanes C, Satue-Gracia E, Vila-Rovira A, et al.
J Stroke Cerebrovasc Dis
. 2014 Mar;
23(6):1577-84.
PMID: 24656243
Background: Cerebrovascular benefits using the 23-valent pneumococcal polysaccharide vaccine (PPV23) are controversial. This study assessed clinical effectiveness of PPV23 in preventing ischemic stroke in people older than 60 years. Methods:...
18.
Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A
Hum Vaccin Immunother
. 2012 May;
8(5):639-44.
PMID: 22634442
Background: The effectiveness of the 23-valent polysaccharide pneumococcal vaccine (PPV-23) is controversial, especially among people with high-risk conditions. This study assessed the clinical effectiveness of vaccination against pneumonia among patients...
19.
Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, et al.
BMC Public Health
. 2012 Mar;
12:222.
PMID: 22436146
Background: Conflicting results have been recently reported evaluating the relationship between pneumococcal vaccination and the risk of thrombotic vascular events. This study assessed the clinical effectiveness of the 23-valent polysaccharide...